Ignore him. He has shown himself to be an utter imbecile on multiple occasions. He wouldn't know in vivo from in vitro, or a petri dish from from a dish of potpourri. He can't even see the complete fallibility of Ti*-*ank. That would be with a T and W.
I've been building CYP steadily. I am as mythed by this sell down as I was surprised by it finished at $0.225 after the into/soph' raise. Not looking a gift horse in the mouth. MSB just got added to the NASDAQ bio-tech index. IPSC's are the ultimate future of MSC's, not adipose or bone marrow derived MSC's from healthy young adults. I wouldn't be surprised if even MSB itself took a good look at CYP to protect its future. Sumitomo of course made a $200 million play for CYP when it was less progressed in trials. If people think it or others and even Fujifilm Cellular Dynamics itself, are not looking at CYP at $50-100 million and licking their lips on MSB approval, they are stark raving.
If, still an if, despite MSB rallying to $2, MSB gets FDA approval, this thing is going to fly. $0.30+ easily. Once they cotton on to the funded trials at UniSyd and LUMC it will go far higher. I can hear the wombles typing on their AI interfaces "what stocks are like Mesoblast?" already. Actually maybe I should buy woeful Athersys in advance of their ignorant buying.
(20min delay)